Conditions: Glaucoma, Open-Angle Ocular Hypertension
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 800
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of bimatoprost 0.01% in subjects with elevated intraocular pressure (IOP) due to primary open-angle glaucoma (POAG) or ocular hypertension (OH).

Detailed description:

Arms:
arm 1: 1 drop in the affected eye(s), administered in the evening in previously treatment naive subjects for 12 weeks. arm 2: 1 drop in the affected eye(s), administered in the evening in subjects who were previously on another monotherapy treatment for 12 weeks. arm 3: 1 drop in the affected eye(s), administered in the evening in subjects who are also receiving adjunctive therapy for 12 weeks.

Interventions: intervention 1: Bimatoprost 0.01%
Intervention descriptions: intervention 1: 1 drop in the affected eye(s), administered in the evening for 12 weeks.

Protocol document: